Suppliers · Companies House 05040260
Glenmark Pharmaceuticals Europe Limited public sector contracts
Glenmark Pharmaceuticals Europe Limited (Companies House 05040260) has won 3 UK public-sector contracts listed on Tendarix, worth £40,639,000 in stated value, from 2 buyers. Its most frequent buyer is NHS England (2 awards). 2 of its contracts run past today.
From award notices. Companies House record
Contracts won
- NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
NHS England · £14,758,000 · awarded Feb 2026 · runs to Sep 2027
- NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
NHS England · £25,881,000 · awarded Nov 2025 · runs to Sep 2027
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18
Regional Business Services Organisation, Procurement and Logistics Service